GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-131 | NA | Western Blotting followed by IF staining and SFA | NA | 0.52 | 1 | 29575240
|
CD44 | 1681 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-131 | Cisplatin | SFA followed by Western Blotting and FACs | NA | 0.52 | 1 | 31585633
|
KLF4 | 6348 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-131 | NA | Western Blotting followed by IF staining and SFA | NA | 0.52 | 0.0891 | 29575240
|
KLF4 | 6348 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-131 | Cisplatin | SFA followed by Western Blotting | NA | 0.52 | 0.0891 | 31585633
|
MYC | 7553 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-131 | NA | Western Blotting followed by IF staining and SFA | NA | 0.52 | 0.1304 | 29575240
|
MYC | 7553 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-131 | Cisplatin | SFA followed by Western Blotting | NA | 0.52 | 0.1304 | 31585633
|
POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-131 | NA | Western Blotting followed by IF staining and SFA | NA | 0.52 | 0.6448 | 29575240
|
POU5F1 | 9221 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-131 | Cisplatin | SFA followed by Western Blotting | NA | 0.52 | 0.6448 | 31585633
|
SOX2 | 11195 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-131 | NA | Western Blotting followed by IF staining and SFA | NA | 0.52 | 0.5695 | 29575240
|
CTNNB1 | 2514 | LTM | Head and Neck Cancer | Squamous Cell Carcinoma | SCC-131 | Cisplatin | SFA followed by Western Blotting | NA | 0.28 | 0.0647 | 31585633
|